Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MEGAN M KELSEY

Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology

NPI
1194871707
CMS profile
995458
Location
AURORA, CO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$475.02

9 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $475.02 9

By paying entity

PY2019 · entire year · sorted by reported total

Paying entityAmountRecords
Covidien LP $475.02 9

Page 1 of 1; records 1–9 of 9 matching records. This page contains 9 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MEGAN M KELSEY

NPI 1194871707 · CMS profile ID 995458

Allopathic & Osteopathic Physicians / Pediatrics / Pediatric Endocrinology

AURORA, CO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–9 of 9 matching records. This page contains 9 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1194871707?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MEGAN M KELSEY, NPI 1194871707, CMS profile ID 995458. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–9 of 9 matching records. This page contains 9 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1194871707?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). MEGAN M KELSEY, NPI 1194871707, CMS profile ID 995458. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–9 of 9 matching records. This page contains 9 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1194871707?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
MEGAN M KELSEY, NPI 1194871707, CMS profile ID 995458, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–9 of 9 matching records. This page contains 9 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1194871707?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

9 matching records · $475.02 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 9 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–9 of 9.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Covidien LP $125.4511/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 636997465 CMS
Covidien LP $16.1111/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 636997469 CMS
Covidien LP $36.8711/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 636997473 CMS
Covidien LP $105.9107/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 636997489 CMS
Covidien LP $14.5807/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 636997493 CMS
Covidien LP $20.4907/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 636997497 CMS
Covidien LP $118.3107/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 636997477 CMS
Covidien LP $18.4407/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 636997481 CMS
Covidien LP $18.8607/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 636997485 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $475.02 9
PY2020 $175.25 3
PY2021 $46.33 2
PY2023 $122.02 1
PY2024 $93.20 1
PY2025 $112.11 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $299,741.00 86
PY2024 Principal investigator $253,768.62 14
PY2023 Principal investigator $32,802.04 9
PY2022 Principal investigator $75,883.99 13
PY2021 Principal investigator $4,583.00 1
PY2019 Principal investigator $39,278.27 13

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

86 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $674.40 12/31/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Phase III, Multicenter, Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Sitagliptin in Pediatric Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control No dispute reported 06/30/2026 1232917997
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,150.00 12/19/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076858
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,040.00 12/19/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076860
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $5,000.00 12/19/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076862
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,000.00 12/19/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076864
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $378.00 12/19/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076866
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $740.25 12/19/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076868
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $80.64 12/19/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076870
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $63.00 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076872
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $163.49 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076874
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $2,220.75 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076876
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $241.92 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076878
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $441.00 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076880
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $94.50 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076882
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $630.00 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076884
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $4,000.00 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076886
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $189.00 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076888
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $6,930.00 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076890
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $1,890.00 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076892
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $760.00 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076894
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $189.00 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076896
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $7,500.00 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076898
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $4,500.00 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076900
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $31.50 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076902
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $441.00 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076904
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $441.00 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076906
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $126.00 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076908
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $1,500.00 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076910
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $378.00 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076912
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $189.00 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076914
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $378.00 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076916
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $94.50 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076918
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $31.50 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076920
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $756.00 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076922
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,540.60 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076924
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,540.60 12/17/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076926
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $11,040.30 12/15/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Trial of Setmelanotide in Acquired Hypothalamic Obesity No dispute reported 06/30/2026 1240076776
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,540.60 09/08/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076808
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $2,883.76 08/18/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Trial of Setmelanotide in Acquired Hypothalamic Obesity No dispute reported 06/30/2026 1240076772
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $5,438.99 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076810
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,540.60 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076812
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,540.60 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076814
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,918.60 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076816
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $4,044.60 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076818
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $5,111.39 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076820
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,162.60 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076822
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,540.60 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076824
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $5,438.99 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076826
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,540.60 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076828
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,540.60 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076830
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,918.60 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076832
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $4,044.60 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076834
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $5,111.39 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076836
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,162.60 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076838
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $4,000.50 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076840
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $5,438.99 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076842
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,540.60 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076844
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,540.60 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076846
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,918.60 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076848
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $4,044.60 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076850
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $5,111.39 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076852
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,162.60 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076854
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,540.60 08/11/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076856
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $5,767.52 07/21/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Trial of Setmelanotide in Acquired Hypothalamic Obesity No dispute reported 06/30/2026 1240076774
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $11,523.60 06/18/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Trial of Setmelanotide in Acquired Hypothalamic Obesity No dispute reported 06/30/2026 1240076768
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $8,651.28 05/20/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Trial of Setmelanotide in Acquired Hypothalamic Obesity No dispute reported 06/30/2026 1240076770
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $1,475.33 04/09/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Trial of Setmelanotide in Acquired Hypothalamic Obesity No dispute reported 06/30/2026 1240076766
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $12,538.64 03/26/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Trial of Setmelanotide in Acquired Hypothalamic Obesity No dispute reported 06/30/2026 1240076760
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $1,710.00 03/19/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076798
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $2,216.25 03/19/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076800
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $1,552.50 03/19/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076806
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $14,738.60 02/18/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Trial of Setmelanotide in Acquired Hypothalamic Obesity No dispute reported 06/30/2026 1240076764
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,001.54 02/14/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
Setmelanotide in Pediatric Patients With Rare Genetic Diseases of Obesity No dispute reported 06/30/2026 1240076928
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $15,225.09 01/20/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Trial of Setmelanotide in Acquired Hypothalamic Obesity No dispute reported 06/30/2026 1240076762
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $4,000.50 01/08/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076778
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $1,552.50 01/08/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076780
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $4,000.50 01/08/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076782
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,405.00 01/08/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076784
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $1,710.00 01/08/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076786
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $1,552.50 01/08/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076792
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,405.00 01/08/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076796
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $1,552.50 01/08/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076804
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,780.00 01/03/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076788
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $6,400.00 01/03/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076790
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $3,000.00 01/03/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076794
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $14,840.00 01/03/2025 Covered Recipient Teaching Hospital
Childrens Hospital Colorado
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity No dispute reported 06/30/2026 1240076802